Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Cancer Research UK
German Cancer Research Center
Revolution Medicines, Inc.
Memorial Sloan Kettering Cancer Center
Duke University
Merck KGaA, Darmstadt, Germany